Search

Search Results

• Endometriosis and ovarian cancer - what they have in common?

  Natalia Zarankiewicz, Katarzyna Kosz, Aleksandra Kuchnicka, Martyna Zielińska, Natalia Wolanin, Bogumiła Ciseł

  230-239

  2020-08-17
• Targeted therapy with Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of solid tumours

  Faustyna Piędel, Agata Agnieszka Rocka, Klaudia Daria Szumna, Dominika Katarzyna Madras, Patryk Piotr Jasielski

  133-139

  2020-03-27
• Neoadjuvant chemotherapy for IIIC stage ovarian cancer - case report

  Aleksandra Obuchowska, Arkadiusz Standyło, Alicja Ozga, Justyna Wójcik, Karolina Obuchowska, Paweł Skorupski

  84-91

  2020-09-04
• The latest reports on biomarkers used in the diagnosis of ovarian cancer

  Aleksandra Chałupnik, Zuzanna Chilimoniuk, Maciej Dobosz, Anna Sobstyl, Małgorzata Sobstyl

  799-809

  2022-08-02
• The role of soy in development of breast, ovarian, endometrial and prostate gland cancer

  Marcela Maksymowicz, Piotr Machowiec, Natalia Baran, Małgorzata Piekarska

  180-186

  2021-09-11
• Роль гомеостатистических механизмов в формировании результативности платинолечения больных с раком яичника = Role homeostatistic mechanisms in the formation of performance platinum treatment of patients with ovarian cancer

  A. I. Rybin

  405-414

  2016-06-17
• Mechanisms of drug resistance in ovarian cancer

  Klaudia Żak, Michał Piwoński, Paweł Stanicki, Karolina Kalicka, Justyna Nowaczek

  362-367

  2021-09-21
• Роль цикла оксида азота в формировании особенностей течения рака яичника = Role of nitrogen oxide cycle in the formation features of the current ovarian cancer

  A. Ribin

  399-404

  2015-11-25
• Особенности процессов детоксикации у больных раком яичника с разной чувствительностью к препаратам платины = Features detoxification process ovarian cancer patients with different sensitivity to platinum drugs

  A. I. Ribin

  686-690

  2015-12-31
• Current ideas about molecular genetic subtypes of ovarian cancer: a personalized approach and a new platform for further research

  A. Rybin

  157-168

  2021-11-26
• Risk factors of ovarian cancer: family history, obesity and oral contraceptive use

  Aleksandra Amalia Kuchnicka, Martyna Zielińska, Natalia Zarankiewicz, Katarzyna Kosz, Halina Piecewicz-Szczęsna

  397-402

  2020-09-18
• Sexuality and fertility of young women suffering from breast cancer

  Martyna Zielińska, Natalia Zarankiewicz, Katarzyna Kosz, Aleksandra Kuchnicka, Jakub Aleksandrowicz, Katarzyna Książek, Sylwia Mojsym-Korybska

  775-785

  2019-08-02
• Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer

  A. I. Rybin, V. Y. Maksymovskyj, V. V. Pyrogov, R. Ya. Demidchik, A. O. Varabina

  412-417

  2018-10-31
• Selected effects of combined oral contraceptives use

  Julia Bogucka, Anna Brzyska, Natalia Domańska, Małgorzata Bojarska, Natalia Wilczek, Halina Piecewicz-Szczęsna

  259-272

  2022-08-31
• The quality of life of patients with ovarian cancer as an indicator of functional assessing the effectiveness of anticancer therapy

  O. O. Kolesnik, A. I. Rybin

  539-551

  2017-05-31
• Ovarian tumors - epidemiology, diagnosis and prevention in Poland

  Agata Ulenberg, Grzegorz Ulenberg

  299-310

  2018-11-16
• Modern strategies of platinum resistance overcoming in patients with the serous ovarian cancer

  Andriy Rybin

  594-599

  2018-11-30
• Endometriosis and an increased risk of malignancies

  Aleksandra Maria Krasa, Magdalena Kozioł, Halina Piecewicz-Szczęsna, Mateusz Pawlicki, Anna Łopuszyńska, Paulina Krawiec, Ewa Piekarska

  290-298

  2020-09-12
• Clinical significancy of WNT pathway inhibition in various cancers

  Patryk Rogaczewski, Michał Janiak , Kamil Borysewicz, Tadeusz Głos, Navid Ahmadi, Łukasz Szylberg

  183-191

  2022-11-03
• Results of treatment of cancer patients with peritoneal carcinomatosis

  O. Bondar, A. Rybin, A. Varabina

  304-314

  2022-05-31
• Have thyroid hormones an impact on ovarian cancer?

  Klaudia Żak, Sylwiusz Niedobylski, Milena Leziak, Karolina Maliszewska, Mirella Czapska, Katarzyna Skórzyńska-Dziduszko

  803-809

  2018-12-31
• Bisophosphonates in the treatment of osteoporosis in women with breast cancer

  Joanna Wolska

  357-363

  2019-09-09
• TIMP way to stop metastasis?

  Katarzyna Jarosz, Robert Chudzik, Maria Gołębiowska, Beata Gołębiowska

  598-604

  2017-08-03
• Long-term results of the enzyme glutation system activity in experimental ovarian cancer

  L. Yershova, R. Yeromenko, I. Savytskyi, T. Alexandryna, L. Sarakhan

  344-351

  2022-02-28
• Hyaluronic acid in gynecology and obstetrics

  Anna Małgorzata Łopuszyńska, Łukasz Ochyra, Mateusz Pawlicki, Halina Piecewicz-Szczęsna

  335-340

  2022-04-30
• Ultrasound investigation central hemodynamics as a method of assessment effective analgesia in children

  K. Y. Dmytriieva

  207-212

  2016-06-10